Canadian Willowherb™Atrium Biotechnologies

Under this partnership, Atrium has been granted the exclusive global rights to represent Fytokem’s products to the personal care and nutraceutical product markets.

Atrium develops and markets nutritional supplements and active ingredients for use in personal care products. With its multi-disciplinary team and its vast international research and marketing network, Atrium acts as an exchange point for technology companies aiming for rapid access to global markets. With its subsidiaries, Atrium markets over 500 products in 20 countries to industry leaders such as Estée Lauder, L’Oréal, Clarins, Chanel, Aventis and Nestlé.

Atrium is a privately held subsidiary of the publicly traded pharmaceutical company, Aeterna Laboratories Inc. (TSX: AEL; NASDAQ: AELA).

La fameuse pilule bleue generique est disponible en ligne en France.

Download news release (pdf 136K): November 29, 2002 - Fytokem Announces Atrium Biotechnologies as New Marketing Partner

Link to Atrium Biotechnologies website

HomeThe CompanyProducts & SolutionsTechnologiesPartnershipsInvestorsNewsContact Us